Trading Ideas

U.S. Senator Kelly Loeffler said on Wednesday she would liquidate her individual stock share positions after the wealthy Republican and her husband were criticized over sales of millions of dollars in stock during the coronavirus outbreak. Loeffler, who was appointed to her Senate seat in January by Georgia’s governor, has repeatedly denied any wrongdoing. In a Wall Street Journal opinion column on Wednesday, Loeffler said she was not changing her investment strategy because she has to. …read more […]

After weeks of historic uncertainty, global stock markets are quickly settling down from now what is now nearly a month of record share price volatility. It appears that social distancing is helping slow new cases of the coronavirus, and there is hope that the global economy will return back to normal. Many stocks have bounced significantly from their lows because of this hope, but there are still plenty of deals to be had.Some well capitalized energy firms, which are already operating in uncertain times as many economies around the world remain in standby mode from the social distancing required to …read more […]

…read more […]

Stimulus checks to arrive by April 15 for millions of taxpayers. A new portal where some can supply direct deposit information could be out next week. …read more […]

(Bloomberg) — Zoom Chief Executive Officer Eric Yuan pledged that his company will meet the highest security standards, seeking to put millions of new users at ease after numerous security lapses on the video-meeting application.Zoom Video Communications Inc. is launching a feature called Security that sets all privacy settings to their highest level, including putting passwords on meetings and employing waiting rooms that force meeting hosts to filter conference attendees, Yuan said Wednesday on a webinar. The San Jose, California-based company is planning to roll out upgraded encryption for its video calls and meeting rooms for large webinars.“Zoom is safe …read more […]

The battle against COVID-19 is well underway, and now’s the time to send in the big guns. Sorrento Therapeutics (SRNE) is on it, offering both active and passive immunization strategies. As a result, it has received positive investor attention, as demonstrated by its 35% one-month gain.As part of these efforts, the healthcare name, which develops therapies to reduce the malignancy of life-threatening tumors, improves the safety of current treatments and brings solutions to make living with cancer more tolerable, partnered with Celularity. Celularity is a privately-held cell therapeutics company that specializes in transformative allogeneic cellular therapies developed from the postpartum …read more […]

The stock market often experiences turbulence in times of economic instability. It can be nerve-wracking to watch your portfolio go up and down over the course of a week, only to end down four, five or more percentage points. When this happens, murmurings of a stock market crash tend to creep into headlines. Are they warranted? What is a stock market crash?
Stock market crashes are very real and devastating when they occur. But they’re not as simple as the market closing down three or four days in a row. A loss of four or five basis points in a day …read more […]

Bernie Sanders drops out of the presidential race. Yahoo Finance’s Rick Newman joins the On The Move panel to weigh in. …read more […]

Owners snooze through refinance opportunities while rates return to historic lows. …read more […]

Amid the ongoing public health crisis, Wall Street is eagerly awaiting any piece of good news. Inovio Pharmaceuticals (INO) just came through.On Monday, the vaccine maker, which is up 150% year-to-date, announced that the Investigational New Drug (IND) application for its experimental COVID-19 vaccine, INO-4800, had been accepted by the FDA. Additionally, management revealed that the first patient in the Phase 1 trial had been dosed with the DNA vaccine candidate.Commenting on the development, H.C. Wainwright analyst Raghuram Selvaraju said, “We note that this constitutes a validating milestone for Inovio’s DNA medicine platform—i.e., to rapidly develop and advance a vaccine …read more […]

Nervous about all of the security and privacy issues facing Zoom? These 4 alternatives will help. …read more […]

With the war against COVID-19 waging on, Wall Street focus has locked in on the names at the frontline. Battling a formidable opponent capable of spreading without a trace, innovative technologies will be required to arm the world’s population. As such, market watchers are standing at the ready, hoping to identify the healthcare companies that can deliver effective weapons against the deadly virus.Pluristem Therapeutics (PSTI) has a fighting chance. On April 7, the company reported its treatment for acute respiratory failure and inflammatory complications caused by COVID-19 had demonstrated robust preliminary results from the compassionate use program, sending shares 21% …read more […]

Yahoo Finance’s Jared Blikre breaks down the latest market action. He joins the On The Move panel to discuss. …read more […]

…read more […]

Costco’s stock looks ripe for further gains during the coronavirus pandemic, strategists say. …read more […]